Continued Respiratory Therapy Phone: 866-382-0799


What Are the Categories of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)?

Duane Reed, EdD, RRT, RCP

August 26, 2021

Share:

Question

What are the categories of non-steroidal anti-inflammatory drugs (NSAIDs)?

Answer

Categories of NSAIDs

  • Cromolyn-like agents
  • Antileukotriene
  • Monoclonal antibodies

Cromolyn-Like Agents

Cromolyn-like agents are called mast cell stabilizers. The mast cell contains anti-inflammatory or inflammatory agents that go to the lungs to help out what it perceives as danger. However, when the mast cells go to specific areas, it causes more inflammation. The cromolyn-like agents keep the mast cell intact by stabilizing those cells in the body. The primary cromolyn-like agent is called Cromolyn Sodium. The drug agent can eliminate some inflammation in patients with Asthma, and it can be an alternative to low-dose corticosteroid therapy. Cromolyn Sodium is administered orally or by a small volume nebulizer. For respiratory therapists, giving the drug agent using a small volume nebulizer is typical instead of administering a drug agent orally. When Cromolyn Sodium is administered orally, the drug routes through the stomach lining and lipid layers to take effect. When we administer the Cromolyn Sodium by a small volume nebulizer, the drug travels directly contacting the lungs and helps alleviate the inflammation. Most of the time, we will give these drugs in combination with steroids to reduce the overall dose of steroids. Keep in mind, the benefit of this category of drugs we are discussing, and anytime we can use the drug agents to help with inflammation, we should.

Antileukotrienes

Antileukotrienes drug agents block the release of leukotriene, which is a form of inflammation in Asthma. Leukotrienes consist of fatty acids, and when those fatty acids go to the specific area of inflammation, it creates a problem. For example, during bronchoconstriction, the body senses something and sends leukotrienes to the inflamed area to help, but this action creates further inflammation in an already aggravated area. Antileukotrienes not only protect the fatty acids but is a potent bronchodilator. We will continue to hear more about antileukotrienes as we are starting to discover the causes of inflammation in current research.

Monoclonal Antibodies

You may have heard about monoclonal antibodies when talking about COVID-19 patients. The monoclonal antibodies are administered in patients with COVID-19 to treat inflammation around the heart. Immunoglobulins are classified into five categories: IgA, IgD, IgE, IgG, and IgM. Immunoglobulin IgG mainly blocks the "G" antibodies. When the body releases the IgG antibodies, it goes to the lungs and causes inflammation. Typically, the monoclonal antibodies are used to treat severe Asthma inflammation in the lungs by controlling the IgG antibodies.

This Ask the Expert is an edited excerpt from the course, Drug Agents for Respiratory Care, presented by Dr. Duane Reed, EdD, RRT, RCP.


duane reed

Duane Reed, EdD, RRT, RCP

Dr. Duane Reed received his Doctoral degree in Education from Walden University. He completed his Master’s degree in Adult Education from Central Michigan University and his Bachelor’s degree in Advanced Respiratory Care from Weber State University.

Dr. Reed is the respiratory care program director at Southern Crescent Technical College. His clinical experience entails over 20 years as a respiratory care practitioner at Grady Memorial Hospital in Atlanta, Georgia, working in critical care areas of surgical, cardiac, medical, and neurointensive care units. Over the last ten years, Dr. Reed has contributed to educational publishing companies as a clinical editor and senior reviewer.

Additionally, Dr. Reed owns Pulmonary Education Consultants, LLC, a company providing respiratory care educational materials and tutoring services. He has authored study cards in areas of mechanical ventilation, which are nationally published, helping respiratory therapists around the country.


Related Courses

Autogenic Drainage: Technique for Airway Clearance
Presented by Duane Reed, EdD, RRT, RCP
Video

Presenter

Duane Reed, EdD, RRT, RCP
Course: #1560Level: Introductory1 Hour
  'Very well-presented lecture , easy to understand and grasp '   Read Reviews
An introductory course on autogenic drainage introduces the practitioner to this airway clearance technique focusing on the indications, procedure, and monitoring of patient outcomes.

Respiratory Management of Patients With Neuromuscular Weakness Series: Review Recommendations and Best Practice
Presented by Duane Reed, EdD, RRT, RCP
Video

Presenter

Duane Reed, EdD, RRT, RCP
Course: #1827Level: Intermediate1 Hour
  'Great presentation and easy to understand'   Read Reviews
An essential concern in neuromuscular diseases (NMD) is respiratory failure. This course reviews guidelines and evidenced-based literature on the best practice respiratory management of patients with NMD. It is part of an NMD series but can be viewed as a stand-alone learning experience.

Drug Agents for Respiratory Care
Presented by Duane Reed, EdD, RRT, RCP
Video

Presenter

Duane Reed, EdD, RRT, RCP
Course: #1318Level: Introductory1 Hour
  'The Instructor has a way of making complicated topics understandable and relatable'   Read Reviews
This introductory course provides a foundational review of the pharmacokinetics and pharmacodynamics of general respiratory drug agents in current use. The course focuses on the classification, mechanism of action, and therapeutic effects.

Respiratory Management of Patients with Neuromuscular Weakness Series: Review of the Grading of Recommendations for Assessment, Development, and Evaluations
Presented by Duane Reed, EdD, RRT, RCP
Video

Presenter

Duane Reed, EdD, RRT, RCP
Course: #1846Level: Introductory1 Hour
  'I love love love his teaching style, I feel like I learn more and the correct answers stick in my brain because of the explainations and repetition of correct answers'   Read Reviews
Clinical experts comprised a multi-professional panel to conduct a systematic review to address patients with neuromuscular diseases (NMD). A review of evidenced-based grading of recommendations and management of patients with NMD is discussed. It is part of an NMD series but can be viewed as a stand-alone learning experience.

Mechanical Ventilation: Weaning Process
Presented by Duane Reed, EdD, RRT, RCP
Video

Presenter

Duane Reed, EdD, RRT, RCP
Course: #1541Level: Introductory1 Hour
  'Well - presented lecture with new knowledge and understanding on weaning that I never learned during my clinical experience ! Very informative'   Read Reviews
The course introduces the practitioner to criteria and procedures for standard weaning in mechanical ventilation. The course discusses indicators used to predict weaning success and failure in mechanical ventilation.

Our site uses cookies to improve your experience. By using our site, you agree to our Privacy Policy.